Get the Stockscreener App
0.2194
7.02%
0.0144
After Hours:
.21
-0.0094
-4.28%
Syros Pharmaceuticals Inc Stock (SYRS) Forecast
The Syros Pharmaceuticals Inc (SYRS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $23.94, representing a +10,813% increase from the current price of $0.2194. The highest analyst price target is $37.30, and the lowest is $10.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SYRS Price Target
Average 48.82
(+22,154% Upside)
Is Syros Pharmaceuticals Inc (SYRS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.85 | Neutral |
| STOCH(9,6) | 31.02 | Neutral |
| STOCHRSI(14) | 91.04 | Sell |
| MACD(12,26) | -0.0744 | Buy |
| ADX(14) | 15.05 | Neutral |
| William %R | -77.77 | Neutral |
| CCI(14) | -47.96 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2287
Sell
|
0.2244
Sell
|
| MA20 |
0.222
Sell
|
0.2532
Sell
|
| MA50 |
0.5329
Sell
|
0.6131
Sell
|
| MA100 |
1.235
Sell
|
1.3916
Sell
|
| MA200 |
3.1527
Sell
|
2.472
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SYRS could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on SYRS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.85 indicates that SYRS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 31.02 indicates that SYRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.04 indicates that SYRS is oversold. This suggests that SYRS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.05 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.96 indicates that SYRS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term SYRS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Syros Pharmaceuticals Inc financial reports and earnings history, Syros Pharmaceuticals Inc (SYRS) stock could reach $66.88 by 2030, $52.15 by 2040 and $145.24 by 2050. See the projected annual prices until 2050 of the Syros Pharmaceuticals Inc stock below:
- Syros Pharmaceuticals Inc (SYRS) is expected to reach an average price of $18.66 in 2035, with a high prediction of $20.56 and a low estimate of $18.76. This indicates an $8,403% rise from the last recorded price of $0.2194.
- Syros Pharmaceuticals Inc (SYRS) stock is projected to chart a bullish course in 2040, with an average price target of $49.80, representing an $22,598% surge from its current level. The forecast ranges from a conservative $50.31 to a sky-high $52.15.
- Our analysts predict Syros Pharmaceuticals Inc (SYRS) to jump 41,332% by 2045, soaring from $91.69 to an average price of $90.90, potentially reaching $91.91. While $91.69 is the low estimate, the potential upside is significant.
- Syros Pharmaceuticals Inc (SYRS) stock is expected to climb by 2050, reaching an average of $143.98, a $65,525% jump from its current level. However, a wide range of estimates exists, with high and low targets of $145.24 and $145.28, respectively, highlighting the market's uncertainty.
Syros Pharmaceuticals Inc Stock (SYRS) Year by Year Forecast
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2025
Syros Pharmaceuticals Inc Stock (SYRS) is expected to reach an average price of $48.82 in 2025, with a high prediction of $97.03 and a low estimate of $0.6223. This indicates an +22,154% rise from the last recorded price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $13.85 | $10.59 | $37.30 | +6,214% |
| March, 2025 | $3.3184 | $2.1094 | $24.71 | +1,412% |
| April, 2025 | $4.2378 | $0.6223 | $9.4262 | +1,832% |
| May, 2025 | $33.85 | $4.1583 | $34.75 | +15,330% |
| June, 2025 | $41.37 | $25.86 | $54.67 | +18,755% |
| July, 2025 | $47.29 | $33.19 | $52.09 | +21,453% |
| August, 2025 | $63.80 | $45.54 | $74.60 | +28,981% |
| September, 2025 | $71.72 | $42.67 | $76.81 | +32,589% |
| October, 2025 | $49.89 | $47.34 | $97.03 | +22,639% |
| November, 2025 | $39.95 | $36.65 | $58.05 | +18,111% |
| December, 2025 | $19.27 | $16.57 | $54.07 | +8,685% |
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2026
The predicted value for Syros Pharmaceuticals Inc (SYRS) in 2026 is set at an average of $56.33. Estimates vary from a peak of $110.91 to a trough of $1.7481, indicating an +25,574% surge from the present price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $34.89 | $18.78 | $49.48 | +15,802% |
| February, 2026 | $76.40 | $27.35 | $79.70 | +34,724% |
| March, 2026 | $96.02 | $54.52 | $110.91 | +43,665% |
| April, 2026 | $69.94 | $57.34 | $110.12 | +31,778% |
| May, 2026 | $48.66 | $23.45 | $72.34 | +22,076% |
| June, 2026 | $22.97 | $21.67 | $52.06 | +10,370% |
| July, 2026 | $10.89 | $6.1909 | $27.02 | +4,864% |
| August, 2026 | $18.71 | $9.0938 | $29.40 | +8,426% |
| September, 2026 | $14.02 | $9.7248 | $19.71 | +6,292% |
| October, 2026 | $8.2404 | $4.6365 | $14.83 | +3,656% |
| November, 2026 | $15.16 | $1.7481 | $15.56 | +6,808% |
| December, 2026 | $8.0753 | $6.1753 | $18.96 | +3,581% |
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Syros Pharmaceuticals Inc (SYRS) is $38.44, with a high forecast of $76.51 and a low forecast of $0.3704. This indicates an +17,422% increase from the last price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.2908 | $5.5908 | $11.79 | +2,767% |
| February, 2027 | $3.6063 | $3.4063 | $11.10 | +1,544% |
| March, 2027 | $1.0257 | $0.5179 | $8.9218 | +367.50% |
| April, 2027 | $6.4588 | $0.3704 | $4.9373 | +2,844% |
| May, 2027 | $15.24 | $11.65 | $12.15 | +6,848% |
| June, 2027 | $20.52 | $17.09 | $18.33 | +9,255% |
| July, 2027 | $18.81 | $20.21 | $19.06 | +8,473% |
| August, 2027 | $17.79 | $19.80 | $18.80 | +8,010% |
| September, 2027 | $21.65 | $20.96 | $76.51 | +9,767% |
| October, 2027 | $17.86 | $19.06 | $20.07 | +8,039% |
| November, 2027 | $18.48 | $18.35 | $17.72 | +8,324% |
| December, 2027 | $16.67 | $17.72 | $17.65 | +7,499% |
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2028
In 2028, Syros Pharmaceuticals Inc (SYRS) is projected to reach an average price of $15.93, with a high projection of $19.05 and a low estimate of $12.81. This indicates an +7,161% rise from the last price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.59 | $17.74 | $17.12 | +7,918% |
| February, 2028 | $18.15 | $18.40 | $18.08 | +8,173% |
| March, 2028 | $18.55 | $18.49 | $19.05 | +8,356% |
| April, 2028 | $18.62 | $18.81 | $18.92 | +8,385% |
| May, 2028 | $18.52 | $18.51 | $18.38 | +8,340% |
| June, 2028 | $16.46 | $16.62 | $17.93 | +7,403% |
| July, 2028 | $15.86 | $15.50 | $16.04 | +7,127% |
| August, 2028 | $15.96 | $15.74 | $15.74 | +7,173% |
| September, 2028 | $15.77 | $15.85 | $15.71 | +7,086% |
| October, 2028 | $14.31 | $14.51 | $15.22 | +6,421% |
| November, 2028 | $12.71 | $12.85 | $13.65 | +5,692% |
| December, 2028 | $12.47 | $12.81 | $12.51 | +5,584% |
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2029
The 2029 price forecast for Syros Pharmaceuticals Inc Stock (SYRS) is $29.58 on average, with a high prediction of $59.12 and a low estimate of $0.0477. This represents an +13,384% increase from the previous price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.62 | $10.83 | $12.28 | +4,741% |
| February, 2029 | $9.7864 | $9.7864 | $10.40 | +4,361% |
| March, 2029 | $9.0409 | $9.2609 | $9.5425 | +4,021% |
| April, 2029 | $9.5654 | $8.705 | $9.0454 | +4,260% |
| May, 2029 | $8.336 | $8.666 | $9.5315 | +3,699% |
| June, 2029 | $7.6605 | $7.8005 | $7.7483 | +3,392% |
| July, 2029 | $1.715 | $3.305 | $5.2166 | +681.66% |
| August, 2029 | $1.3456 | $1.6756 | $1.5433 | +513.30% |
| September, 2029 | $0.4101 | $0.8501 | $0.5817 | +86.90% |
| October, 2029 | $0.3807 | $0.0477 | $0.8416 | +73.50% |
| November, 2029 | $1.2952 | $1.2968 | $0.8929 | +490.32% |
| December, 2029 | $59.52 | $0.0565 | $59.12 | +27,029% |
Syros Pharmaceuticals Inc Stock (SYRS) Price Forecast for 2030
Syros Pharmaceuticals Inc Stock (SYRS) is expected to reach an average price of $40.36 in 2030, with a high forecast of $67.16 and a low forecast of $13.56. This signifies an +18,296% surge from the last price of $0.2194.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $72.38 | $63.40 | $66.88 | +32,891% |
| February, 2030 | $38.75 | $45.15 | $56.27 | +17,562% |
| March, 2030 | $43.52 | $51.92 | $49.43 | +19,736% |
| April, 2030 | $14.79 | $17.45 | $29.21 | +6,640% |
| May, 2030 | $16.15 | $13.56 | $15.95 | +7,261% |
| June, 2030 | $65.72 | $36.64 | $50.62 | +29,854% |
| July, 2030 | $71.03 | $66.90 | $66.88 | +32,274% |
| August, 2030 | $44.45 | $70.15 | $67.16 | +20,159% |
| September, 2030 | $35.62 | $46.42 | $43.33 | +16,134% |
| October, 2030 | $32.63 | $35.61 | $35.69 | +14,772% |
| November, 2030 | $64.45 | $41.42 | $46.76 | +29,274% |
| December, 2030 | $47.92 | $58.33 | $48.74 | +21,740% |
0.65%
4.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):